View : 5 Download: 0
Noninvasive aspergillosis following COVID-19 exacerbates the severity of SARS-CoV-2 infection
- Title
- Noninvasive aspergillosis following COVID-19 exacerbates the severity of SARS-CoV-2 infection
- Authors
- Kim, Jong Seung; Park, Jun Hyung; Kim, Juhyun; Lee, Yong Chul; Yang, Ji Won; You, Yeon Seok; Kim, Gwangsu; Kim, Wankyu; Jeong, Jae Seok
- Ewha Authors
- 김완규
- SCOPUS Author ID
- 김완규

- Issue Date
- 2026
- Journal Title
- INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- ISSN
- 1201-9712
1878-3511
- Citation
- INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES vol. 172
- Keywords
- COVID-19; Respiratory aspergillosis; Transcriptome
- Publisher
- ELSEVIER SCI LTD
- Indexed
- SCIE; SCOPUS

- Document Type
- Article
- Abstract
- Objectives: Few large-scale population-based studies have examined the association between COVID-19 and respiratory aspergillosis. Using nationwide data, we investigated whether SARS-CoV-2 infection increases respiratory aspergillosis incidence and whether COVID-19-associated aspergillosis affects COVID19 severity. We also analyzed public COVID-19 transcriptomic datasets to assess effects on airway structural and immune cells. Design or Methods : From a nationwide cohort of 8.5 million clinical registries, we included over 550,0 0 0 patients diagnosed with COVID-19 between October 8, 2020, and December 31, 2021, and matched controls. Outcomes were respiratory aspergillosis incidence, including invasive and noninvasive forms, and its association with COVID-19 severity. Results: COVID-19 was associated with increased subsequent respiratory aspergillosis. Diabetes, COPD, and other comorbidities further increased fungal infection incidence among COVID-19 patients. Both invasive and noninvasive aspergillosis were associated with greater COVID-19 severity. Systemic corticosteroid use markedly increased severity and mortality in both forms. Antifungal-related genes and pathways, including CCR6, CXCL9, and CX3CR1, were consistently downregulated after SARS-CoV-2 infection and/or corticosteroid treatment. Conclusion: COVID-19 was associated with increased respiratory aspergillosis incidence, and respiratory aspergillosis was associated with worse COVID-19 outcomes regardless of invasiveness. Further studies should evaluate whether antifungal treatment improves COVID-19 outcomes. on behalf of International Society for Infectious ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
- DOI
- 10.1016/j.ijid.2026.109095
- Appears in Collections:
- 자연과학대학 > 생명과학전공 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML